封面
市场调查报告书
商品编码
1698440

乳房重建市场:2025-2030 年预测

Breast Reconstruction Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计 2025 年乳房重建市场价值将达到 1,659,276,000 美元,复合年增长率为 6.61%,预计到 2030 年市场规模将达到 2,285,049,000 美元。

随着全球乳癌发生率的不断上升,预计市场将出现强劲成长。此外,预计对乳房切除术后即时手术的需求不断增加将在预测期内推动市场成长。此外,由于技术的进步和公司提供各种植入和网片形式的产品,乳房重建市场拥有良好的成长前景。

市场趋势:

  • 乳癌患者数量的增加推动了市场成长:全球乳癌发生率的增加推动了乳房切除术后乳房重建手术的需求。根据世界卫生组织预测,2022年将有230万名女性被诊断出罹患乳癌,其中许多人都是推迟乳房重建或修復先前重组手术的潜在候选人,这将进一步推动市场扩张。
  • 乳房重建技术的进步:乳房重建技术的创新导致了更自然的乳房植入的开发,从而推动了市场的成长。
  • 亚太地区的成长潜力:由于乳癌患者数量的增加以及治疗后重组的需求不断增加,预计亚太地区的乳房重建市场将显着增长。例如,根据全球癌症观察站的数据,2022 年印度的乳癌患者数量将达到 98,337 人,位居世界首位,凸显了该地区对重组解决方案的需求日益增长。
  • 北美市场领导地位:由于其先进的医疗保健基础设施和主要市场参与者的存在,北美预计将占据全球乳房重建市场的巨大份额。例如,美国医疗设备公司 Sientra 提供经 FDA 批准的高强度凝聚性硅胶乳房植入,仅供委员会认证的整形外科医生使用,从而促进了该地区的市场成长。

本报告涉及的主要企业包括 Allergan Aesthetics、强生、Integra Lifesciences、RTI Surgical Inc. 和 Bimini Health Tech。

本报告的主要优点

  • 深刻分析:获得涵盖主要和新兴地区的深入市场洞察,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局:了解全球主要企业所采用的策略策略,并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素:探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议:利用洞察力进行策略决策,在动态环境中开闢新的业务流和收益。
  • 受众广泛:对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途?

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测分析(包括国家在内的细分市场和地区)
  • 公司概况(策略、产品、财务资讯、主要趋势等)

目录

第一章 引言

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章乳房重建市场(按类型)

  • 介绍
  • 植入
    • 硅胶植入
    • 生理食盐水植入
  • 组织扩张器

第六章乳房重建市场切除术

  • 介绍
  • 另一方面
  • 两个都

第七章乳房重建市场(依最终用户)

  • 介绍
  • 医院
  • 美容诊所
  • 门诊手术中心

第八章乳房重建市场:按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Johnson & Johnson Services, Inc.
  • Allergan Aesthetics
  • RTI Surgical Inc.
  • Integra LifeSciences Corporation
  • GC Aesthetics
  • Sientra, Inc.

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613790

The Breast Reconstruction Market, valued at US$1,659.276 million in 2025, is projected to grow at a CAGR of 6.61% reaching a market size of US$2,285.049 million by 2030.

With the growing incidences of breast cancer globally, the market is projected to show strong growth prospects. The rising demand for immediate breast reconstruction procedures following mastectomy further allows the market to thrive in the forecast period. Furthermore, with technological advancements and companies offering varied products in the form of implants or mesh, the market for breast reconstruction holds favourable growth prospects.

Market Trends:

  • Rising Breast Cancer Cases Driving Market Growth: The increasing global incidence of breast cancer is boosting demand for breast reconstruction procedures post-mastectomy. According to the WHO, 2.3 million women were diagnosed with breast cancer in 2022, many of whom are potential candidates for delayed breast reconstruction or revisions of previous reconstructions, further fueling market expansion.
  • Technological Advancements in Breast Reconstruction: Innovations in breast reconstruction technology are leading to the development of more natural-looking breast implants, driving growth in the market.
  • Asia-Pacific's Growth Potential: The Asia-Pacific region is expected to see significant growth in the breast reconstruction market due to rising breast cancer cases and increasing demand for reconstruction post-treatment. For instance, data from the Global Cancer Observatory shows that India reported the highest number of breast cancer cases in 2022, with 98,337 cases, highlighting the region's growing need for reconstruction solutions.
  • North America's Market Leadership: North America is projected to hold a substantial share of the global breast reconstruction market, supported by advanced healthcare infrastructure and the presence of leading market players. For example, Sientra, a U.S.-based medical device company, offers FDA-approved high-strength cohesive silicone gel breast implants, available exclusively to board-certified plastic surgeons, contributing to the region's market growth.

Some of the major players covered in this report include Allergan Aesthetics, Johnson & Johnson, and Integra Lifesciences, RTI Surgical Inc., Bimini Health Tech. among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Breast Reconstruction Market is analyzed into the following segments:

By Type

  • Implants
  • Silicone Implants
  • Saline Implants
  • Tissue Expander

By Mastectomy

  • Unilateral
  • Bilateral

By End-User

  • Hospitals
  • Cosmetology Clinics
  • Ambulatory Surgery Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. BREAST RECONSTRUCTION MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Implants
    • 5.2.1. Silicone Implants
    • 5.2.2. Saline Implants
  • 5.3. Tissue Expander

6. BREAST RECONSTRUCTION MARKET BY MASTECTOMY

  • 6.1. Introduction
  • 6.2. Unilateral
  • 6.3. Bilateral

7. BREAST RECONSTRUCTION MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Cosmetology Clinics
  • 7.4. Ambulatory Surgery Centers

8. BREAST RECONSTRUCTION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Mastectomy
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Mastectomy
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Mastectomy
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Mastectomy
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Mastectomy
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Johnson & Johnson Services, Inc.
  • 10.2. Allergan Aesthetics
  • 10.3. RTI Surgical Inc.
  • 10.4. Integra LifeSciences Corporation
  • 10.5. GC Aesthetics
  • 10.6. Sientra, Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations